Oliviero James F III 4
4 · Checkpoint Therapeutics, Inc. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Award
COMMON STOCK
2024-12-13+2,077,700→ 4,016,980 total
Footnotes (2)
- [F1]Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024.
- [F2]Includes shares of restricted common stock, which vest over various time periods.